EUCTR2004-003765-32-IT进行中（未招募）不适用
INDUCTIVE CHEMIOTHERAPY WITH CISPLATIN AND GEMTABICINE FOLLOWED BY TOMOTHERAPY WITH METABOLIC GUIDE FOR THE TREATMENT OF PATIENTS AFFECTED BY PULMONARY CARCINOMA (NOT SMALL CELL)IN LOCALLY ADVANCED STAGE: PILOT STUDY OF PHASE II
OSPEDALE S. RAFFAELE0 个研究点开始时间: 2008年1月8日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
招募中
1 期
Gemcitabine and carboplatin induction chemotherapy followed by concurrent cisplatin and IMRT for locally advanced nasopharyngeal cancerACTRN12605000509662Peter MacCallum Cancer Centre30
已完成
2 期
Concomitant radiotherapy and weekly cisplatin with or without prior induction chemotherapy with cisplatin, epirubicin and paclitaxel (CEP) in patients with locally advanced nasopharyngeal carcinomaocally advanced nasopharyngeal carcinomaLocally advanced nasopharyngeal carcinomaCancer - Head and neckACTRN12609000730202Hellenic Cooperative Oncology Group148
进行中（未招募）
不适用
Induction Chemotherapy with Gemcitabine-Oxaliplatin GEM-OXA followed by concomitant weekly Gemcitabine plus Radiotherapy GEM/RT in Locally Advanced, Unresectable Pancreatic Cancer A Phase II Study - gemoxa followed by gem-rtocally advanced pancreatic cancerMedDRA version: 6.1Level: HLTClassification code 10033633EUCTR2005-005063-29-ITISTITUTI FISIOTERAPICI OSPITALIERI56
进行中（未招募）
不适用
SEQUENTIAL CHEMOTHERAPY WITH CISPLATIN PLUS VINORELBINE FOLLOWED BY WEEKLY DOCETAXEL IN LOCALLY ADVANCED OR METASTATIC NON SMALL-CELL LUNG CANCER - NDEUCTR2008-003250-15-ITAZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
已完成
2 期
Induction Chemotherapy With Gemcitabine and Cisplatin Followed by CCRT for Unresectable Pancreatic CarcinomaPancreatic Carcinoma Non-resectableNCT01593475National Cancer Center, Korea44